Upadacitinib for moderate to severe atopic dermatitis with generalized prurigo nodularis

被引：0
|
作者：
Lou, Fanglu [1 ,2 ,3 ,4 ]
Wang, Yuyi [1 ,2 ,3 ,4 ]
Xiao, Yujuan [1 ,2 ,3 ,4 ]
Liu, Yi [1 ,2 ,3 ,4 ]
机构：
[1] Chongqing Coll Tradit Chinese Med, Affiliated Hosp 1, Dept Dermatol, Chongqing 400011, Peoples R China
[2] Chongqing Hosp Tradit Chinese Med, Dept Dermatol, 40 Daomenkou St, Chongqing 400011, Peoples R China
[3] Chongqing Key Lab Integrat Dermatol Res, Chongqing, Peoples R China
[4] Chongqing Clin Res Ctr Dermatol, Chongqing, Peoples R China
来源：
ASIAN JOURNAL OF SURGERY | 2024年 / 47卷 / 07期
基金：
中国国家自然科学基金;
关键词：
D O I：
10.1016/j.asjsur.2024.02.127
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：3084 / 3088
页数：5
相关论文
共 50 条
  • [21] The efficacy and immunological effects of upadacitinib in the treatment of moderate-to-severe Chinese atopic dermatitis patients
    Li, Lu
    Wu, Naming
    Liu, Tingyu
    Yu, Guoqun
    Wang, Yifei
    He, Ting
    Mao, Raymond
    Yang, Liu
    Li, Yan
    Shen, Chen
    Tao, Juan
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 125
  • [22] Dupilumab and prurigo nodularis-like phenotype in atopic dermatitis: our experience of efficacy
    Ferrucci, S.
    Tavecchio, S.
    Berti, E.
    Angileri, L.
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2021, 32 (04) : 453 - 454
  • [23] HIV-related exclusion criteria in atopic dermatitis and prurigo nodularis clinical trials
    Leibowitz, Rebecca
    Fischer, Anna
    Collins, Lauren F.
    Feldman, Ron J.
    Yeung, Howa
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 91 (02) : 352 - 354
  • [24] ASSOCIATION BETWEEN PRURIGO NODULARIS AND INATTENTION AND HYPERACTIVITY/IMPULSIVITY IN PEDIATRIC PATIENTS WITH ATOPIC DERMATITIS
    Shin, Jun-Oh
    Lee, Jungsoo
    Shin, Kihyuk
    Kim, Hoon-Soo
    Kim, Byung-Soo
    Kim, Moon-Bum
    Ko, Hyunchang
    ACTA DERMATO-VENEREOLOGICA, 2022, 102 : 50 - 50
  • [25] Association between atopic dermatitis and prurigo nodularis: a systematic review and meta-analysis
    Li, Wei
    Pi, Yunze
    Xu, Jiwei
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2024, : 282 - 286
  • [26] RNA sequencing reveals the transcriptome profile of the atopic prurigo nodularis with severe itching
    Shao, Yixin
    Zhu, Yiqi
    Xiao, Zijing
    Shen, Yanyun
    Dai, Beiying
    Tang, Hui
    Wang, Duoqin
    EXPERIMENTAL DERMATOLOGY, 2023, 32 (01) : 30 - 40
  • [27] Efficacy and Safety of Upadacitinib for Management of Moderate-to-Severe Atopic Dermatitis: An Evidence-Based Review
    Lytvyn, Yuliya
    Mufti, Asfandyar
    Abduelmula, Abrahim
    Sachdeva, Muskaan
    Maliyar, Khalad
    Georgakopoulos, Jorge R.
    Yeung, Jensen
    PHARMACEUTICS, 2022, 14 (11)
  • [28] Effectiveness and safety of upadacitinib retreatment after withdrawal in moderate-to-severe atopic dermatitis: a retrospective study
    Hagino, Teppei
    Saeki, Hidehisa
    Fujimoto, Eita
    Kanda, Naoko
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2024, : 770 - 778
  • [29] Upadacitinib effectiveness in moderate-to-severe atopic dermatitis: A real-life multicentre and retrospective study
    Ramos, F. Javier Melgosa
    Gonzalez-Delgado, Victor
    Motilla, Jose Maria Sanchez
    Marta, Galarreta Pascual
    Mateu Puchades, Almudena
    Sergio, Santos Alarcon
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2023, 64 (04) : e361 - e364
  • [30] Clinical and pharmacokinetic results of upadacitinib in Chinese healthy subjects and subjects with moderate-to-severe atopic dermatitis
    Zheng, Min
    Zhang, Chunlei
    Fang, Hong
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB30 - AB30
12345